Loading...
1α,25-dihydroxyvitamin D(3) promotes osseointegration of titanium implant via downregulating AGEs/RAGE pathway in T2DM
Diabetes-induced advanced glycation end products (AGEs) overproduction would result in compromised osseointegration of titanium implant and high rate of implantation failure. 1α,25-dihydroxyvitamin D(3) (1,25VD(3)) plays a vital role in osteogenesis, whereas its effects on the osseointegration and t...
Saved in:
| Published in: | Endocr Connect |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bioscientifica Ltd
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215803/ https://ncbi.nlm.nih.gov/pubmed/30352411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|